The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
2 – Suzanne M. de la Monte and Jack R. Wands, Journal of Diabetes Science and Technology 2, no. 6, 1101–13, November 2008
Alzheimer’s Disease Is Type 3 Diabetes – Evidence Reviewed
3 – Stephen C. Cunnane et al., Annals of the New York Academy of Sciences 1367, no. 1, January 2016
Can Ketones Compensate for Deteriorating Brain Glucose Uptake During Aging? Implications for the Risk and Treatment of Alzheimer’s Disease
4 – J. J. Sevigny et al., Neurology 71, no. 21, 1702–08, November 2008
Growth Hormone Secretagogue MK-677
5 – Sung-Wuk Jang et al., Proceedings of the National Academy of Sciences of the United States of America 107, no. 6, 2687–92, February 2010
A Selective TrkB Agonist with Potent Neurotrophic Activities by 7,8-Dihydroxyflavone
6 – Nian-Sheng Tzeng et al., Neurotherapeutics 15, no. 2, 417–29,, February 2018
Anti-Herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections – A Nationwide, Population-Based Cohort Study in Taiwan
1 – https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm,
To calculate your BMI, you can use online tools such as the BMI calculator on the National Heart, Lung, and Blood Institute website
2 – Dale E. Bredesen, Aging 6, no. 9, 707–17, September 2014
Reversal of Cognitive Decline: A Novel Therapeutic Program
2 – Dale E. Bredesen et al., Aging 8, no. 6, 1250–58, June 2016
Reversal of Cognitive Decline in Alzheimer’s Disease
2 – Dale E. Bredesen et al., Journal of Alzheimer Disease & Parkinsonism 8, no. 5, 450, October 2018
Reversal of Cognitive Decline: 100 Patients
2 – Do Young Kim et al., PloS One 10, no. 4, e0119316, April 2015